2019 Vaccine Guide & Insert - 12

HEPATITIS B

Hepatitis B
What causes hepatitis B?
Hepatitis B is a liver disease caused by the hepatitis B virus (HBV).
How serious is infection with hepatitis B
Hepatitis B can be very serious. Infection with this virus can cause chronic infection that can
lead to cirrhosis and liver cancer. Many people in the United States die every year from hepatitis
B related liver disease. Fortunately, there is a vaccine to prevent acute (recently acquired)
hepatitis B.
Who should get hepatitis B vaccine?
Hepatitis B vaccine, usually a three‐dose series, is recommended for all children 0 through 18
years of age. It is recommended for infants beginning at birth in the hospital. All older children
who did not get all the recommended doses of hepatitis B vaccine as an infant should complete
their vaccine series as soon as possible. Most states require hepatitis B vaccine for school entry.
Adolescents who are just starting their series will need two or three doses, depending on their
age and the brand of vaccine used. Adults at increased risk of acquiring hepatitis B infection
should also be vaccinated. In addition, the vaccine can be given to any person who desires
protection from hepatitis B.

Adults at increased
risk of acquiring
hepatitis B infection
should also be
vaccinated. In
addition, the vaccine
can be given to any
person who desires
protection from
hepatitis B.

Who is at increased risk of hepatitis B infection?
* Healthcare workers and public safety workers with reasonably anticipated risk for exposure
to blood or blood‐contaminated body fluids
* People with diabetes
* Men who have sex with men
* People with HIV infection
* Sexually active people who are not in long‐term, mutually monogamous relationships
* People seeking evaluation or treatment for a sexually transmitted disease
* Current or recent injection drug users
* Inmates of long‐term correctional facilities
* People with end‐stage kidney disease, including predialysis, hemodialysis, peritoneal dialysis,
and home dialysis patients
* People with chronic liver disease
* Staff and residents of institutions or group homes for the developmentally challenged
* Household members and sex partners of people with chronic hepatitis B virus infection
* Susceptible (non‐infected and non‐vaccinated) people from United States populations known
to previously or currently have high rates of childhood hepatitis B infection, including Alaska
Natives, Pacific Islanders, and immigrants or refugees from countries with intermediate
or high rates of chronic hepatis B virus infection; (see a map of these countries at
wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseasesrelated-to-travel/hepatitis-b
* Travelers to regions with high or intermediate rates of hepatitis B virus infection;
(see a map of these countries at wwwnc.cdc.gov/travel/yellowbook/2016/infectiousdiseases-related-to-travel/hepatitis-b
Source: http://www.immunize.org/catg.d/p4205.pdf
CPT Information
Administration CPT Code without
physician counseling

90471, 90472, 90473 or 90474

Administration CPT Code with
physician counseling

90460 or 90461

ENGERIX‐B

90746 (Adult) 90744 (Pediatric)

RECOMBIVAX HB

90746 (Adult) 90744 (Pediatric)

For informational purposes only. Source: ReimbursementCodes.com and/or www.cms.gov. Customer is responsible for verification of billing/coding in accordance with applicable specific circumstances.
See manufacturer package insert for full prescribing information.
†

To Order: 1.800.P.SCHEIN (1.800.772.4346) 8am-8:30pm, et

To Fax: 1.800.329.9109 24 Hrs

19MS4037

http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseasesrelated-to-travel/hepatitis-b https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/hepatitis-b https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/hepatitis-b http://www.immunize.org/catg.d/p4205.pdf http://www.ReimbursementCodes.com http://www.cms.gov

2019 Vaccine Guide & Insert

Table of Contents for the Digital Edition of 2019 Vaccine Guide & Insert